You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

XL184

Showing 26 - 50 of 127
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Large Cell Neuroendocrine Carcinoma, Metastatic Neuroendocrine Carcinoma, Metastatic Neuroendocrine Tumor Trial in

Active, not recruiting
  • Metastatic Large Cell Neuroendocrine Carcinoma
  • +3 more
  • Cabozantinib S-malate
  • +2 more
  • Birmingham, Alabama
  • +46 more
Dec 30, 2022

Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Philadelphia (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 2, 2022

Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma Trial in Houston

Active, not recruiting
  • Differentiated Thyroid Gland Carcinoma
  • +3 more
  • Computed Tomography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2022

Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer Trial in Mobile (Cabozantinib 40 MG oral once a day,

Terminated
  • Cervical Cancer
  • +3 more
  • Cabozantinib 40 MG oral once a day
  • Pembrolizumab 200 mg IV every 3 weeks
  • Mobile, Alabama
    University of South Alabama Mitchell Cancer Institute
Jun 3, 2022

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (drug, radiation,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Aug 3, 2021

Kidney Cancer, Renal Cell Carcinoma Trial in New Brunswick, New York, Cleveland (Cabozantinib, Nivolumab, Cytoreductive

Recruiting
  • Kidney Cancer
  • Renal Cell Carcinoma
  • New Brunswick, New Jersey
  • +2 more
Mar 22, 2022

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Bone Scan
  • +7 more
  • (no location specified)
Jan 18, 2023

Advanced Metastatic Melanoma Trial in Iowa City (Cabozantinib, Pembrolizumab)

Recruiting
  • Advanced Metastatic Melanoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Sep 13, 2021

Locally Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, Metastatic Paraganglioma Trial in Houston

Recruiting
  • Locally Advanced Paraganglioma
  • +5 more
  • Cabozantinib S-malate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 7, 2021

Urothelial Carcinoma, Urethral Tumors, Urinary Bladder Tumors Trial run by the NCI (Cabozantinib)

Active, not recruiting
Has Results
  • Urothelial Carcinoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Non Small Cell Lung Cancer (NSCLC), Metastases to the Brain Trial in Pittsburgh (cabozantinib)

Terminated
Has Results
  • Non Small Cell Lung Cancer (NSCLC)
  • Metastases to the Brain
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute- Hillman Cancer Center
Mar 8, 2021

Locally Advanced Hepatocellular Carcinoma Trial in Baltimore (Cabozantinib, Nivolumab)

Active, not recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 18, 2021

Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

Active, not recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +35 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +7 more
Jan 3, 2023

Lung Cancer, Solid Tumor (Not Breast or Prostate Cancers) Trial in Boston (Cabozantinib)

Completed
Has Results
  • Lung Cancer
  • Solid Tumor (Not Breast or Prostate Cancers)
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 8, 2020

Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma Trial in Canada, United States

Active, not recruiting
  • Advanced Endometrial Carcinoma
  • +4 more
  • Cabozantinib S-malate
  • Nivolumab
  • Phoenix, Arizona
  • +33 more
Nov 1, 2022

Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)

Recruiting
  • Metastatic Papillary Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer AJCC v8
  • Atezolizumab
  • +4 more
  • Sacramento, California
  • +38 more
Jan 17, 2023

Breast Cancer Trial in Boston, New York (Cabozantinib, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +3 more
May 6, 2021

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

Colorectal Cancer Trial in Durham (Panitumumab, Cabozantinib)

Completed
  • Colorectal Cancer
  • Durham, North Carolina
    Duke Cancer Center, Duke University Medical Center
Feb 9, 2021

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Advanced Hepatocellular Carcinoma Trial in Japan (Cabozantinib)

Completed
  • Advanced Hepatocellular Carcinoma
  • Nagoya, Aichi, Japan
  • +16 more
Aug 25, 2021

Advanced Renal Cell Carcinoma Trial in Japan (Cabozantinib)

Completed
Has Results
  • Advanced Renal Cell Carcinoma
  • Nagoya, Aichi, Japan
  • +18 more
Aug 22, 2021

Hepatocellular Carcinoma Trial in Worldwide (Cabozantinib tablets, Placebo tablets)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Cabozantinib tablets
  • Placebo tablets
  • Corona, California
  • +103 more
Apr 8, 2021

Thyroid Cancer Trial in Worldwide (XL184, Placebo)

Completed
Has Results
  • Thyroid Cancer
  • XL184
  • Placebo
  • Birmingham, Alabama
  • +113 more
Mar 30, 2021